Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Frey

Showing results (381-390 of 475) with videos related to

Pageof 48
Sort By:
Journal of Affective Disorders|October 28, 2021
Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study reportKaterina Rnic, Young-Eun Jung, Ivan Torres, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 9, 2020
Structural covariance pattern abnormalities of insula in major depressive disorder: A CAN-BIND study reportRuiyang Ge, Stefanie Hassel, Stephen R Arnott, et al.
Neuroimage. Clinical|July 31, 2022
Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 reportJacqueline K Harris, Stefanie Hassel, Andrew D Davis, et al.
Bipolar Disorders|January 24, 2013
The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and futureLakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 10, 2007
Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorderCarrie E Bearden, Paul M Thompson, Rebecca A Dutton, et al.
Translational Psychiatry|August 22, 2021
Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant responseLaura M Fiori, Massimiliano Orri, Zahia Aouabed, et al.
Pharmacopsychiatry|July 6, 2022
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) StudyHelena K Kim, Gwyneth Zai, Daniel J Müller, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 21, 2023
Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 reportRaegan Mazurka, Simone Cunningham, Stefanie Hassel, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 13, 2016
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation, S F Marshall, R Burghaus, et al.
Bipolar Disorders|March 26, 2013
Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelinesAyal Schaffer, Sagar V Parikh, Sidney H Kennedy, et al.
Pageof 48

Showing results (381-390 of 475) with videos related to

Sort By:
Pageof 48
Journal of Affective Disorders|October 28, 2021
Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study reportKaterina Rnic, Young-Eun Jung, Ivan Torres, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 9, 2020
Structural covariance pattern abnormalities of insula in major depressive disorder: A CAN-BIND study reportRuiyang Ge, Stefanie Hassel, Stephen R Arnott, et al.
Neuroimage. Clinical|July 31, 2022
Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 reportJacqueline K Harris, Stefanie Hassel, Andrew D Davis, et al.
Bipolar Disorders|January 24, 2013
The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and futureLakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 10, 2007
Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorderCarrie E Bearden, Paul M Thompson, Rebecca A Dutton, et al.
Translational Psychiatry|August 22, 2021
Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant responseLaura M Fiori, Massimiliano Orri, Zahia Aouabed, et al.
Pharmacopsychiatry|July 6, 2022
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) StudyHelena K Kim, Gwyneth Zai, Daniel J Müller, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 21, 2023
Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 reportRaegan Mazurka, Simone Cunningham, Stefanie Hassel, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 13, 2016
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation, S F Marshall, R Burghaus, et al.
Bipolar Disorders|March 26, 2013
Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelinesAyal Schaffer, Sagar V Parikh, Sidney H Kennedy, et al.
Pageof 48